This device maker has fragile business model which may soon become victim of medicare reimbursement changes, reducing is current payment by 50%. 2 billion dollar business suddenly then becomes worth 1 billion by government edict. Most insurers will then base their reimbursement on the changes.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.